Posttraumatic Heterotopic Ossification

Posttraumatic Heterotopic Ossification

No Results

No Results

processing….

In 1918, Dejerine and Ceillier first described heterotopic ossification (HO) in paraplegic patients injured in World War I, referring to the process as paraosteoarthropathy. HO has been defined as the formation of mature lamellar bone in soft tissues. The process involves true osteoblastic activity and bone formation. HO has been reported in cases of brain injury, spinal cord injury, stroke, poliomyelitis, myelodysplasia, tabes dorsalis, carbon monoxide poisoning, spinal cord tumors, syringomyelia, tetanus, and multiple sclerosis. This condition also has been reported after burns and total hip replacement/joint arthroplasty. [1]

Several terms have been used to describe the condition, including heterotopic ossification, ectopic ossification, and myositis ossificans. HO usually involves the large joints of the body (eg, hips, elbows, shoulders, knees). Excessive bone formation may result in significant disability by severely limiting the range of motion (ROM) of these joints (see image below).

In a study of patients who suffered a traumatic spinal cord injury, Ohlmeier et al, examining the frequency of heterotopic ossification (HO) in muscle groups around the hip, found HO to be most prevalent in the gluteal muscle group (55.8%). The second-highest prevalence (31.1%) was reported to be in the deep muscle group. [2]

The following 3 categories of HO have been described:

Myositis ossificans progressiva – This is a rare metabolic bone disease in children with progressive metamorphosis of skeletal muscle to bone; it is characterized by an autosomal dominant pattern of genetic transmission.

Myositis ossificans circumscripta without trauma – Also referred to as neurogenic HO, this is a localized soft-tissue ossification occurring after neurologic injury or burns.

Traumatic myositis ossificans – This condition occurs from direct injury to the muscles. Fibrous, cartilaginous, and osseous tissues near bone are affected; the muscle may not be involved.

Related Medscape Reference topics:

Heterotopic Ossification [Physical Medicine and Rehabilitation]

Heterotopic Ossification Imaging [Radiology]

Heterotopic Ossification in Spinal Cord Injury

Pediatric Fibrodysplasia Ossificans Progressiva (Myositis Ossificans)

Traumatic Heterotopic Ossification

Related Medscape resource:

Resource Center Joint Disorders

The specific cause and pathophysiology of heterotopic ossification (HO) remain uncertain, but the condition appears to involve the inappropriate differentiation of mesenchymal cells into osteoblastic stem cells in response to still-unidentified inducing agents.

HO may be due to an interaction between local factors (eg, the pool of available calcium in adjacent skeleton, soft-tissue edema, vascular stasis tissue hypoxia, mesenchymal cells with osteoblastic activity) and an unknown systemic factor or factors. The basic defect in HO is the inappropriate differentiation of fibroblasts into bone-forming cells. Early edema of connective tissue proceeds to tissue with foci of calcification and then to maturation of calcification and ossification.

United States

The reported incidence of heterotopic ossification (HO) varies. In cases of severe trauma or insult to the central nervous system (CNS), 10-20% of patients develop HO, and the condition has been observed in 20% of patients with severe brain injury. The incidence is higher in patients who undergo open reduction and internal fixation of a fracture. With an elbow fracture, dislocation, or fracture-dislocation, the incidence of traumatic HO at the elbow approaches 90%. Traumatic HO of the elbow occurs in 20% of forearm fractures. Fifty-five percent of patients with hip fractures develop HO. The incidence increases to 83% if open reduction and internal fixation are performed. The incidence is similar in the upper and lower extremities.

An association has been cited between spasticity and HO. The incidence is higher in a spastic extremity; 84% of patients with HO had spasticity, and 54% of patients with HO had no spasticity. HO is seen in the elbow in 4% of patients with traumatic brain injury (TBI); however, if fracture or dislocation is associated with brain injury, the incidence of HO rises to 89%.

Related Medscape Reference topics:

Classification and Complications of Traumatic Brain Injury

Traumatic Brain Injury in Children

Traumatic Brain Injury: Definition, Epidemiology, Pathophysiology

International

Studies from Europe and Japan have shown the incidence of HO to range between 11% and 76%, depending on the population studied and on the method of detection.

Only 10-20% of all heterotopic ossification (HO) patients have functionally significant deficits.

No race predilection exists for heterotopic ossification.

The development of heterotopic ossification is independent of the patient’s sex.

An increased incidence of heterotopic ossification (HO) has been found in persons over age 30 years. The incidence of HO in children appears to be lower than that in adults (8-22.5%).

Hurlimann M, Schiapparelli FF, Rotigliano N, Testa E, Amsler F, Hirschmann MT. Influence of surgical approach on heterotopic ossification after total hip arthroplasty – is minimal invasive better? A case control study. BMC Musculoskelet Disord. 2017 Jan 21. 18 (1):27. [Medline]. [Full Text].

Ohlmeier M, Suero EM, Aach M, Meindl R, Schildhauer TA, Citak M. Muscle localization of heterotopic ossification following spinal cord injury. Spine J. 2017 Apr 27. [Medline].

Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med. 1985 Feb. 26(2):125-32. [Medline]. [Full Text].

Freed JH, Hahn H, Menter R. The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy. Paraplegia. 1982 Aug. 20(4):208-16. [Medline].

Svircev JN, Wallbom AS. False-negative triple-phase bone scans in spinal cord injury to detect clinically suspect heterotopic ossification: a case series. J Spinal Cord Med. 2008. 31(2):194-6. [Medline].

Tanaka T, Rossier AB, Hussey RW. Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. Radiology. 1977 Apr. 123(1):217-21. [Medline].

Bachman DR, Kamaci S, Thaveepunsan S, et al. Preoperative nerve imaging using computed tomography in patients with heterotopic ossification of the elbow. J Shoulder Elbow Surg. 2015 Mar 11. [Medline].

Garland DE, Razza BE, Waters RL. Forceful joint manipulation in head-injured adults with heterotopic ossification. Clin Orthop Relat Res. 1982 Sep. 133-8. [Medline].

Hastings H 2nd, Graham TJ. The classification and treatment of heterotopic ossification about the elbow and forearm. Hand Clin. 1994 Aug. 10(3):417-37. [Medline].

Ring D, Jupiter JB. Operative release of complete ankylosis of the elbow due to heterotopic bone in patients without severe injury of the central nervous system. J Bone Joint Surg Am. 2003 May. 85-A(5):849-57. [Medline].

Fingerman G, Krengel W, Lowell JD, et al. Role of Diphosphonate EHDP in the Prevention of Heterotopic Ossification After Total Hip Arthroplasty: Preliminary Report. Proceedings of the Fifth Open Scientific Meeting of the Hip Society, St Louis, Mo. 222-34.

Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg Am. 1981 Feb. 63(2):201-8. [Medline].

Esenwein SA, Sell S, Herr G, et al. Superior efficacy in suppression of heterotopic bone formation using fractionated irradiation of 5 x 2 Gy compared to a single dose of 7 Gy. An experimental study in rats. Acta Orthop Belg. 2003 Apr. 69(2):119-26. [Medline].

Strauss JB, Chen SS, Shah AP, et al. Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty. Int J Radiat Oncol Biol Phys. 2008 Jan 28. [Medline].

Spielman G, Gennarelli TA, Rogers CR. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil. 1983 Nov. 64(11):539-42. [Medline].

Stover SL, Hahn HR, Miller JM 3rd. Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report). Paraplegia. 1976 Aug. 14(2):146-56. [Medline].

Beck A, Salem K, Krischak G, et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the perioperative phase in traumatology and orthopedics effects on bone healing. Oper Orthop Traumatol. 2005 Dec. 17(6):569-78. [Medline].

Fransen M. Preventing chronic ectopic bone-related pain and disability after hip replacement surgery with perioperative ibuprofen. A multicenter, randomized, double-blind, placebo-controlled trial (HIPAID). Control Clin Trials. 2004 Apr. 25(2):223-33. [Medline].

Ritter MA, Gioe TJ. The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty. Clin Orthop Relat Res. 1982 Jul. 113-7. [Medline].

Ritter MA, Sieber JM. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop Relat Res. 1985 Jun. 217-25. [Medline].

Tannenbaum H, Davis P, Russell AS, et al. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. CMAJ. 1996 Jul 1. 155(1):77-88. [Medline]. [Full Text].

Wheeler P, Batt ME. Do non-steroidal anti-inflammatory drugs adversely affect stress fracture healing? A short review. Br J Sports Med. 2005. 2:65-9. [Medline]. [Full Text].

Bek D, Beksaç B, Della Valle AG, et al. Aspirin decreases the prevalence and severity of heterotopic ossification after 1-stage bilateral total hip arthroplasty for osteoarthrosis. J Arthroplasty. 2008 Mar 27. [Medline].

Macfarlane RJ, Ng BH, Gamie Z, et al. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opin Pharmacother. 2008 Apr. 9(5):767-86. [Medline].

Flanagan SR, Kwasnica C, Brown AW, et al. Congenital and acquired brain injury. 2. Medical rehabilitation in acute and subacute settings. Arch Phys Med Rehabil. 2008 Mar. 89(3 Suppl 1):S9-14. [Medline].

Pavey GJ, Polfer EM, Nappo KE, et al. What Risk Factors Predict Recurrence of Heterotopic Ossification After Excision in Combat-related Amputations?. Clin Orthop Relat Res. 2015 Apr 2. [Medline].

Abrams RA, Simmons BP, Brown RA, et al. Treatment of posttraumatic radioulnar synostosis with excision and low-dose radiation. J Hand Surg [Am]. 1993 Jul. 18(4):703-7. [Medline].

Bontke CF, Boake C. Principles of brain injury rehabilitation. Braddom RL, ed. Physical Medicine and Rehabilitation. 2nd ed. Philadelphia, Pa: WB Saunders; 1999.

Finlayson MAJ, Garner SH, eds. Brain Injury Rehabilitation: Clinical Considerations. Baltimore, Md: Williams & Wilkins; 1994.

Buschbacher R. Heterotopic ossification: a review. Crit Rev Phys Med. 1992. 4:199.

Chestnut RM. Medical complications of the head injured patient. Cooper PR, ed. Head Injury. 3rd ed. Baltimore, Md: Williams & Wilkins; 1993.

Chua KS, Kong KH. Acquired heterotopic ossification in the settings of cerebral anoxia and alternative therapy: two cases. Brain Inj. 2003 Jun. 17(6):535-44. [Medline].

Cohly HH, Buckley RC, Pecunia R, et al. Heterotopic bone formation: presentation of an experimental rat model and a clinical case. Biomed Sci Instrum. 2003. 39:446-53. [Medline].

Colachis SC 3rd, Clinchot DM, Venesy D. Neurovascular complications of heterotopic ossification following spinal cord injury. Paraplegia. 1993 Jan. 31(1):51-7. [Medline].

Cope R. Heterotopic ossification. South Med J. 1990 Sep. 83(9):1058-64. [Medline].

Dejerine A, Ceillier A. Paraosteoarthropathies of paraplegic patients by spinal cord lesion. Clinical and roentgenographic study. Clin Orthop Relat Res. 1991 Feb. 3-12. [Medline].

Djergaian RS. Management of musculoskeletal complications. Horn LJ, Zasler ND, eds. Medical Rehabilitation of Traumatic Brain Injury. Philadelphia, Pa: Hanley & Belfus; 1996.

Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev. 2004. CD001160. [Medline].

Freed MM. Traumatic and congenital lesions of the spinal cord. Kottke PS, Stillwell OK, Lehmann JP, eds. Krusen’s Handbook of Physical Medicine and Rehabilitation. 3rd ed. Philadelphia, Pa: WB Saunders; 1982. 643-73.

Fujimori Y, Nakamura T, Ijiri S. Heterotopic bone formation induced by bone morphogenetic protein in mice with collagen-induced arthritis. Biochem Biophys Res Commun. 1992 Aug 14. 186(3):1362-7. [Medline].

Garland DE. A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop Relat Res. 1991 Feb. 13-29. [Medline].

Garland DE, Blum CE, Waters RL. Periarticular heterotopic ossification in head-injured adults. Incidence and location. J Bone Joint Surg Am. 1980 Oct. 62(7):1143-6. [Medline].

Garland DE, Hanscom DA, Keenan MA. Resection of heterotopic ossification in the adult with head trauma. J Bone Joint Surg Am. 1985 Oct. 67(8):1261-9. [Medline].

Garland DE, Orwin JF. Resection of heterotopic ossification in patients with spinal cord injuries. Clin Orthop Relat Res. 1989 May. 169-76. [Medline].

Gean AD. Imaging of Head Trauma. New York, NY: Raven Press; 1994.

Gennarelli TA. Cerebral concussion and diffuse brain injuries. Cooper PA, ed. Head Injury. Philadelphia, Pa: Williams & Wilkins; 1993. 137-58.

Gennarelli TA. Heterotopic ossification. Brain Inj. 1988 Apr-Jun. 2(2):175-8. [Medline].

Glenn M, Rosenthal M. Rehabilitation following severe traumatic brain injury. Semin Neurol. 1985. 5:233-46.

Gonzales-Mas R. Reabilitacion del traumatizado craneoencefalico [in Spanish]. Revista Iberoamericana de Rehabilitacion Medica. 1995. 48(16):1-11.

Harder AT, An YH. The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: a concise review. J Clin Pharmacol. 2003 Aug. 43(8):807-15. [Medline].

Ippolito E, Formisano R, Caterini R, et al. Operative treatment of heterotopic hip ossification in patients with coma after brain injury. Clin Orthop Relat Res. 1999 Aug. 130-8. [Medline].

Keenan MA, Haider T. The formation of heterotopic ossification after traumatic brain injury: a biopsy study with ultra-structural analysis. J Head Trauma Rehabil. 1996. 11(4):8-22.

Khan FA. Bilateral ankylosis of the hips following heterotopic ossification of the ilio-psoas in a child. Int Orthop. 1992. 16(2):202-4. [Medline].

Kitterman JA, Kantanie S, Rocke DM, et al. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics. 2005 Nov. 116(5):e654-61. [Medline]. [Full Text].

Krum SD, Miller F. Heterotopic ossification after hip and spine surgery in children with cerebral palsy. J Pediatr Orthop. 1993 Nov-Dec. 13(6):739-43. [Medline].

Lee M, Alexander MA, Miller F. Postoperative heterotopic ossification in the child with cerebral palsy: three case reports. Arch Phys Med Rehabil. 1992 Mar. 73(3):289-92. [Medline].

Mayer NH, Esquenazi A, Keenan MA. Analysis and management of spasticity, contracture, and impaired motor control. Horn LJ, Zasler NE, eds. Medical Rehabilitation of Traumatic Brain Injury. Philadelphia, Pa: Hanley & Belfus; 1996.

Mital MA, Garber JE, Stinson JT. Ectopic bone formation in children and adolescents with head injuries: its management. J Pediatr Orthop. 1987 Jan-Feb. 7(1):83-90. [Medline].

Mysiw WJ, Fugate LP, Clinchot DM. Assessment, early rehabilitation and tertiary prevention. Horn LJ, Zasler ND, eds. Medical Rehabilitation of Traumatic Brain Injury. Philadelphia, Pa: Hanley & Belfus; 1996.

Naraghi FF, DeCoster TA, Moneim MS, et al. Heterotopic ossification. Orthopedics. 1996 Feb. 19(2):145-51. [Medline].

Neal BC, Rodgers A, Clark T, et al. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand. 2000 Apr. 71(2):122-8. [Medline].

Payne LZ, DeLuca PA. Heterotopic ossification after rhizotomy and femoral osteotomy. J Pediatr Orthop. 1993 Nov-Dec. 13(6):733-8. [Medline].

Pennig D, Mader K, Gausepohl T. [Posttraumatic elbow stiffness: planning and technical aspects of arthrolysis]. Zentralbl Chir. 2005 Feb. 130(1):32-9. [Medline].

Reed MH, McGinn G, Black GB. Heterotopic ossification in children after iliopsoas release. Can Assoc Radiol J. 1992 Jun. 43(3):195-8. [Medline].

Rogers RO. Program idea: heterotopic calcification in severe head injury: a preventive program. Brain Inj. 1988. 2:169.

Ruff RM, Marshall LF, Crouch J. Predictors of outcome following severe head trauma: follow-up data from the Traumatic Coma Data Bank. Brain Inj. 1993 Mar-Apr. 7(2):101-11. [Medline].

Sazbon L, Najenson T, Tartakovsky M. Widespread periarticular new-bone formation in long-term comatose patients. J Bone Joint Surg Br. 1981 Feb. 63-B(1):120-5. [Medline].

Sorenson SB, Kraus JF. Occurrence, severity and outcomes of brain injury. Bone Joint Surg Br. 1981. 63:120.

Stover SL, Niemann KM, Tulloss JR. Experience with surgical resection of heterotopic bone in spinal cord injury patients. Clin Orthop Relat Res. 1991 Feb. 71-7. [Medline].

Trentz OA, Handschin AE, Bestmann L, et al. Influence of brain injury on early posttraumatic bone metabolism. Crit Care Med. 2005 Feb. 33(2):399-406. [Medline].

Whyte J, Hart T, Laborde A, et al. Rehabilitation of the patient with traumatic brain injury. Delisa JA, Gans BM, eds. Rehabilitation Medicine: Principles and Practice. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1998.

Auri Bruno-Petrina, MD, PhD Physiatrist

Auri Bruno-Petrina, MD, PhD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, Canadian Association of Physical Medicine and Rehabilitation, International Society of Physical and Rehabilitation Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Patrick M Foye, MD Director of Coccyx Pain Center, Professor of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School; Co-Director of Musculoskeletal Fellowship, Co-Director of Back Pain Clinic, University Hospital

Patrick M Foye, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Stephen Kishner, MD, MHA Professor of Clinical Medicine, Physical Medicine and Rehabilitation Residency Program Director, Louisiana State University School of Medicine in New Orleans

Stephen Kishner, MD, MHA is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Robert L Sheridan, MD Assistant Chief of Staff, Chief of Burn Surgery, Shriners Burns Hospital; Associate Professor of Surgery, Department of Surgery, Division of Trauma and Burns, Massachusetts General Hospital and Harvard Medical School

Robert L Sheridan, MD is a member of the following medical societies: American Academy of Pediatrics, American Association for the Surgery of Trauma, American Burn Association, American College of Surgeons

Disclosure: Received research grant from: Shriners Hospitals for Children; Physical Sciences Inc, Mediwound.

Posttraumatic Heterotopic Ossification

Research & References of Posttraumatic Heterotopic Ossification|A&C Accounting And Tax Services
Source